Regulation of FMO and PON detoxication systems in ALS human tissues

Neurotoxicity Research

Volumn 23, Issue 4, 2013, Pages 370-377

  Gagliardi, Stella ^a   Abel, Kenneth ^c   Bianchi, Marika ^a   Milani, Pamela ^a,b   Bernuzzi, Stefano ^d   Corato, Manuel ^a,b   Ceroni, Mauro ^a,b   Cashman, John R ^c   Cereda, Cristina ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c HUMAN BIOMOLECULAR RESEARCH INSTITUTE   (United States)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

ALS; Exposure to toxins; FMO; PON; qPCR

Indexed keywords

ARYLDIALKYLPHOSPHATASE; DIMETHYLANILINE MONOOXYGENASE; MESSENGER RNA; TOXIN; XENOBIOTIC AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; DETOXIFICATION; DISEASE ASSOCIATION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MEDULLA OBLONGATA; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; ARYLDIALKYLPHOSPHATASE; BRAIN; CELL LINE; CELLS, CULTURED; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGENASES; SPINAL CORD;

EID: 84876288474     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-012-9356-1     Document Type: Article

References (44)

1. Abel El (2007) Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis. Percept Mot Skills 104(3 Pt 2):1251-1254
2. Ahmed A, Wicklund MP (2011) Amyotrophic lateral sclerosis: what role does environment play? Neurol Clin 29(3):689-711
3. Brooks BR, Miller RG, Swash M, Munsat TL (2000) World federation of neurology research group on motor neuron diseases. El Escorial revisited: revisited criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Later Scler 1:293-299
4. Camarillo C, Swerdel M, Hart R (2011) Comparison of microarray and quantitative real-time PCR methods for measuring MicroRNA levels in MSC cultures. Methods Mol Biol 698(Part 4):419-429
5. Cashman JR (1995) Structural and catalytic properties of the mammalian flavin-containing monooxygenase. Chem Res Toxicol 8(2):166-181
6. Cashman JR, Zhang J (2006) Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 46:65-100
7. Cereda C, Gabanti E, Corato M, de Silvestri A, Alimonti D, Cova E, Malaspina A, Ceroni M (2006) Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 7(4):227-234
8. Li CY, Sung FC (2003) Association between occupational exposure to power frequency electromagnetic fields and amyotrophic lateral sclerosis: a review. Am J Ind Med 43(2):212-220
9. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806
10. Corrado L, Ratti A, Gellera C, Buratti E, Castellotti B, Carlomagno Y, Ticozzi N, Mazzini L, Testa L, Taroni F, Baralle FE, Silani V, D'Alfonso S (2009) High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat 30(4):688-694
11. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE (2003) Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8(1):1-12
12. Gagliardi S, Cova E, Davin A, Cashman JR, Abel K, Ghidoni R, Alvisi E, Ceroni M, Cereda C (2010) Increased SOD1 mRNA levels in sporadic amyotrophic lateral sclerosis patients. Neurobiol Dis 39:198-203
13. Gagliardi S, Ogliari P, Davin A, Corato M, Cova E, Abel K, Cashman JR, Ceroni M, Cereda C (2011) Flavin-containing monooxygenase (FMO) mRNA levels are up-regulated in ALS brain areas in SOD1-mutant mice. Neurotox Res 20:150-158
14. Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR (2007) Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE 2(11):e1205
15. Guengerich FP (1990) Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue. Pharmacol Ther 45(3):299-307
16. Horke S, Witte I, Wilgenbus P, Kruger M, Strand D, Forstermann U (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115:2055-2064
17. Johnson FO, Atchison WD (2009) The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology 30(5):761-765 [Epub 2009 Jul 24]
18. Kawaji A, Isobe M, Tochino Y, Takabatake E, Chikaoka Y, Nomura Y, Tamura M (1998) Flavin-containing monooxygenase mediated metabolism of benzydamine in perfused brain and liver. Biochim Biophys Acta 1425(1):41-46
19. Kisby GE, Ellison M, Spencer PS (1992) Content of the neurotoxins cycasin (methylazoxymethanol beta-d-glucoside) and BMAA (beta-N-methylamino-l-alanine) in cycad flour prepared by Guam Chamorros. Neurology 42(7):1336-1340
20. LeBel CP, Bondy SC (1990) Oxygen radicals: common mediators of neurotoxicity. Neurotoxicol Teratol 13:341-346
21. LeBel CP, Ali S, McKee M, Bondy SC (1990) Organometal-induced increases in oxygen reactive species: the potential of 2′,7′- dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104:341-346
22. Lee SE (2011) Guam dementia syndrome revisited in 2011. Curr Opin Neurol 24(6):517-524
23. Levy E, Trudel K, Bendayan M, Seidman EG, Delvin E, Lavoie JC, Precourt LP, Amre D, Sinnett D (2007) Biological role, protein expression, subcellular localization and oxidative stress response of paraoxonase2 in the intestine of humans and rats. Am J Physiol Gastrointest Liver Physiol 293:G1252-G1261
24. Livak, Schmittgen (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402-408
25. Mahoney DJ, Kaczor JJ, Bourgeois J, Yasuda N, Tarnopolsky MA (2006) Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle Nerv Jun 33(6):809-816
26. Malaspina A, Kaushik N, de Belleroche J (2001) Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77(1):132-145
27. Mulder DW, Kurland LT, Iriarte LL (1954) Neurologic diseases on the island of Guam. US Armed Forces Med J 5(12):1724-1739
28. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276(48):44444-44449
29. Pamphlett R, Waley P (1996) Uptake of inorganic mercury by the human brain. Acta Neuropathol 92(5):525-527
30. Parrón T, Mar R, Hernández AF, Alarcón R (2011) Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmacolog 256(3):379-385
31. Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D'Ascenzo C, Bagarotti A, Pensato V, Ranieri M, Gagliardi S, Calini D, Mazzini L, Taroni F, Corti S, Ceroni M, Oggioni GD, Lin K, Powell JF, Sorarù G, Ticozzi N, Comi GP, D'Alfonso S, Gellera C, Silani V, SLAGEN Consortium (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33(10):2528.e7-2528.e14 [Epub 2012 Jul 4]
32. Ricci C, Battistini S, Cozzi L, Benigni M, Origone P, Verriello L, Lunetta C, Cereda C, Milani P, Greco G, Patrosso MC, Causarano R, Caponnetto C, Giannini F, Corbo M, Penco S (2011) Lack of association of PON polymorphisms with sporadic ALS in an Italian population. Neurobiol Aging 32(3):552.e7-552.e13
33. Rosenblat M, Hayek T, Hussein K, Aviram M (2004) Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler Thromb Vasc Biol 24:175-180
34. Shaw PJ (2005) Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry 76:1046-1057
35. Shiner M, Fuhrman B, Aviram M (2006) A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. Biochem Biophys Res Commun 349:1094-1099
36. Slowik A, Tomik B, Wolkow PP, Partyka D, Turaj W, Malecki MT, Pera J, Dziedzic T, Szczudlik A, Figlewicz DA (2006) Paraoxonase gene polymorphisms and sporadic ALS. Neurology 67(5):766-770
37. Steele JC, McGeer PL (2008) The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 70(21):1984-1990
38. Suh JK, Robertus JD (2000) Role of yeast flavin containing monooxygenases is induced by the unfolded protein response. Proc Natl Acad Sci USA 97:121-126
39. Ticozzi N, LeClerc AL, Keagle PJ, Glass JD, Wills AM, van Blitterswijk M, Bosco DA, Rodriguez-Leyva I, Gellera C, Ratti A, Taroni F, McKenna-Yasek D, Sapp PC, Silani V, Furlong CE, Brown RH Jr, Landers JE (2010) Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol 68(1):102-107
40. Ticozzi N, Tiloca C, Morelli C, Colombrita C, Poletti B, Doretti A, Maderna L, Messina S, Ratti A, Silani V (2011) Genetics of familial amyotrophic lateral sclerosis. Arch Ital Biol 149(1):65-82
41. Urushitani M, Ezzi SA, Matsuo A, Tooyama I, Julien JP (2008) The endoplasmic reticulum-golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J 22(7):2476-2487 [Epub 2008 Mar 12]
42. Weisskopf MG, Ascherio A (2009) Cigarettes and amyotrophic lateral sclerosis: only smoke or also fire? Ann Neurol 65(4):361-362
43. Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3
44. Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME, Furlong CE, Brown RH Jr (2008) Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology 70(12):929-934